EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Prognostic factors affecting survival and recurrence in patients undergoing curative surgery for rectal cancer: a 10-year retrospective cohort study from a regional tertiary center in Türkiye

Merve Yumak, Mehmet Salim Demir

Frontiers in Oncology · 26.01.2026 · 15

DOI: 10.3389/fonc.2025.1679585 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Oncology, online erschienen am 26.01.2026. Verfasst von Merve Yumak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastointestinal Surgery, Van Training and Research Hospital, Van, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rectal cancer remains a major health burden worldwide, with significant morbidity and mortality despite advances in multimodal treatment. Identifying factors associated with postoperative mortality and recurrence is crucial for improving long-term outcomes.

Objective

To evaluate clinical, pathological, and treatment-related predictors of overall survival (OS) and disease-free survival (DFS) in patients who underwent curative surgery for rectal cancer at a regional tertiary care center in Türkiye.

Methods

This retrospective cohort study included 122 patients who underwent rectal cancer surgery between 2013 and 2023 at Van Training and Research Hospital. Demographic, clinical, and pathological variables were recorded, including tumor location, differentiation, lymphovascular invasion (LVI), perineural invasion (PNI), neoadjuvant/adjuvant therapy, and resection margin status. Survival analysis was performed using the Kaplan–Meier method, and independent prognostic factors were identified through multivariate Cox regression.

Results

The median overall survival was 156.0 months (95% CI, 132.4–179.6), and the median disease-free survival was 28.5 months (95% CI, 22.0–36.5). Mortality was significantly associated with LVI (p=0.001), PNI (p=0.007), poor differentiation (p<0.001), R1 resection (p=0.013), emergency surgery (p=0.043), and follow-up metastasis (p<0.001). Patients with LVI had a 3.89-fold increased mortality risk, while follow-up metastasis increased mortality risk 8.75-fold. Recurrence was significantly associated with mid-rectal tumors, advanced T/N stage, LVI, PNI, and positive margins. Elevated carcinoembryonic antigen (CEA) levels were also predictive of poor outcomes.

Conclusion

LVI, PNI, tumor grade, margin status, and follow-up metastasis are strong predictors of recurrence and mortality in rectal cancer surgery. Incorporating these parameters into postoperative risk stratification may enhance surveillance and therapeutic strategies, especially in regional healthcare settings.

Schlagwörter

Stichwörter der Autor:innen

CEAcox regressionlymphovascular invasionneoadjuvant therapyperineural invasionrectal cancerrecurrencesurgical oncology

Autor:innen und Institutionen

  • Department of Gastointestinal Surgery, Van Training and Research Hospital, Van, Türkiye.
  • Department of Medical Oncology, Van Training and Research Hospital, Van, Türkiye.

Zitieren

APA

Yumak, M., & Demir, M. S. (2026). Prognostic factors affecting survival and recurrence in patients undergoing curative surgery for rectal cancer: a 10-year retrospective cohort study from a regional tertiary center in Türkiye. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1679585

Vancouver

Yumak M, Demir MS. Prognostic factors affecting survival and recurrence in patients undergoing curative surgery for rectal cancer: a 10-year retrospective cohort study from a regional tertiary center in Türkiye. Frontiers in Oncology. 2026;15. doi:10.3389/fonc.2025.1679585

BibTeX
@article{Yumak2026,
  author = {Yumak, Merve and Demir, Mehmet Salim},
  title = {Prognostic factors affecting survival and recurrence in patients undergoing curative surgery for rectal cancer: a 10-year retrospective cohort study from a regional tertiary center in Türkiye},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {15},
  doi = {10.3389/fonc.2025.1679585}
}
Kostenlos starten →